HSCT (Autologous Haematopoietic Stem Cell Transplantation) is an effective therapy to fight multiple sclerosis, the level of side effects is acceptable, and the therapy is safe, Ian Franks believes. Now, he answers the question why he has not undergone HSCT himself,
side effects
MS treatment Zinbryta (daclizumab) withdrawn worldwide amid safety concerns
Disease modifying therapy daclizumab (Zinbryta) has been withdrawn from sale worldwide. Its manufacturers took the decision after reports that a number of people taking the treatment developed serious inflammatory brain disorders. That’s how the news was announced on the MS Society’s website. In the UK, the treatment will no longer be available via the country’s … Continue reading MS treatment Zinbryta (daclizumab) withdrawn worldwide amid safety concerns
Zinbryta use restricted in Europe after a death and four serious liver injuries
The European Medicines Agency (EMA) has restricted the use of multiple sclerosis drug Zinbryta. The agency took action after a patient died from liver injury (fulminant liver failure). The patient was in an ongoing observational study. Four cases of serious liver injury have also been reported. We are all likely to experience some side effect … Continue reading Zinbryta use restricted in Europe after a death and four serious liver injuries
Why are DMTs – Drugs to treat MS – Resisted by so Many?
Many people with multiple sclerosis await the launch of each new disease modifying therapy (DMT), hoping it will bring some improvement. Meanwhile, a significant number of those in the same situation seem to ignore a new drug and carry on regardless. But why? Well, there are a number of reasons; let’s take a look at a … Continue reading Why are DMTs – Drugs to treat MS – Resisted by so Many?
New MS drug approved in USA and Europe
A new disease modifying treatment is being considered for use in the UK following it being approved in the USA and Europe. Already approved by America’s Food and Drug Administration (FDA), daclizumab, known as Zinbryta, has now been given the nod by the European Medicines Agency (EMA). The agency has recommended that the drug be … Continue reading New MS drug approved in USA and Europe
Epilepsy drug being tested for multiple sclerosis use
News that the generic drug phenytoin, used as an anti-convulsant to treat epilepsy, is being tested as a treatment for certain types of problems associated with multiple sclerosis, caught me by surprise. Although I am not a doctor or scientist, I can speak with some authority about this drug because I was prescribed it for … Continue reading Epilepsy drug being tested for multiple sclerosis use
